MindWalk Holdings Corp
F:TQB0

Watchlist Manager
MindWalk Holdings Corp Logo
MindWalk Holdings Corp
F:TQB0
Watchlist
Price: 0.94 EUR 8.05%
Market Cap: €43.4m

MindWalk Holdings Corp
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

MindWalk Holdings Corp
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
MindWalk Holdings Corp
F:TQB0
Research & Development
-CA$4.4m
CAGR 3-Years
30%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Research & Development
-$1.4B
CAGR 3-Years
2%
CAGR 5-Years
-3%
CAGR 10-Years
-7%
Danaher Corp
NYSE:DHR
Research & Development
-$1.6B
CAGR 3-Years
-2%
CAGR 5-Years
-3%
CAGR 10-Years
-6%
Waters Corp
NYSE:WAT
Research & Development
-$195.7m
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
-5%
Agilent Technologies Inc
NYSE:A
Research & Development
-$454m
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
-4%
IQVIA Holdings Inc
NYSE:IQV
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

MindWalk Holdings Corp
Glance View

MindWalk Holdings Corp. is an AI-driven biotherapeutic research, technology, and scientifically robust life science company that discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company is headquartered in Austin, Texas. Powered by patented HYFT technology and the LensAI platform, the Company unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

TQB0 Intrinsic Value
1.08 EUR
Undervaluation 13%
Intrinsic Value
Price

See Also

What is MindWalk Holdings Corp's Research & Development?
Research & Development
-4.4m CAD

Based on the financial report for Oct 31, 2025, MindWalk Holdings Corp's Research & Development amounts to -4.4m CAD.

What is MindWalk Holdings Corp's Research & Development growth rate?
Research & Development CAGR 5Y
-26%

Over the last year, the Research & Development growth was 6%. The average annual Research & Development growth rates for MindWalk Holdings Corp have been 30% over the past three years , -26% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett